The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles

Jung Soo Suk, Samuel K. Lai, Ying Ying Wang, Laura Ensign-Hodges, Pamela L. Zeitlin, Michael P. Boyle, Justin S Hanes

Research output: Contribution to journalArticle

Abstract

Highly viscoelastic and adhesive sputum has precluded efficient nanoparticle-based drug and gene delivery to the lungs of patients with cystic fibrosis (CF). We sought to determine whether nanoparticles coated with non-mucoadhesive polymers could penetrate CF sputum, and to use these "muco-inert particles" (MIPs) as non-destructive nanoprobes to characterize the sputum microstructure. Particles as large as 200 nm in diameter that were densely coated with low MW polyethylene glycol (PEG) moved through undiluted CF sputum with average speeds up to 90-fold faster than similarly-sized uncoated particles. On the other hand, the transport of both coated and uncoated 500 nm particles was strongly hindered. The local viscosity of sputum, encountered by the fastest 10% of 200 nm MIPs, was only 5-fold higher than that of water, whereas the bulk viscosity was 10,000-fold higher at low shear rates. Using measured transport rates of various sized MIPs combined with an obstruction-scaling model, we determined that the average 3D mesh spacing of CF sputum is ∼140 ± 50 nm (range: 60-300 nm). Taken together, these results demonstrate that nanoparticles up to 200 nm in diameter that do not adhere to CF sputum can move rapidly through this critical barrier by accessing pores that are filled with a low viscosity fluid. The results also offer hope that desperately needed sputum-penetrating drug- and gene-carrier nanoparticles can be developed for CF.

Original languageEnglish (US)
Pages (from-to)2591-2597
Number of pages7
JournalBiomaterials
Volume30
Issue number13
DOIs
StatePublished - May 2009

Fingerprint

Sputum
Cystic Fibrosis
Nanoparticles
Polymers
Viscosity
Genes
Nanoprobes
Pharmaceutical Preparations
Shear deformation
Polyethylene glycols
Adhesives
Microstructure
Drug Carriers
Fluids
Water
Lung

Keywords

  • Lung disease
  • Mucus
  • Mucus penetrating particles
  • Nanoparticle therapeutics
  • Particle tracking
  • Rheology

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. / Suk, Jung Soo; Lai, Samuel K.; Wang, Ying Ying; Ensign-Hodges, Laura; Zeitlin, Pamela L.; Boyle, Michael P.; Hanes, Justin S.

In: Biomaterials, Vol. 30, No. 13, 05.2009, p. 2591-2597.

Research output: Contribution to journalArticle

Suk, Jung Soo ; Lai, Samuel K. ; Wang, Ying Ying ; Ensign-Hodges, Laura ; Zeitlin, Pamela L. ; Boyle, Michael P. ; Hanes, Justin S. / The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. In: Biomaterials. 2009 ; Vol. 30, No. 13. pp. 2591-2597.
@article{217bf6fc4c724ceba9a458b3bbfddbd0,
title = "The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles",
abstract = "Highly viscoelastic and adhesive sputum has precluded efficient nanoparticle-based drug and gene delivery to the lungs of patients with cystic fibrosis (CF). We sought to determine whether nanoparticles coated with non-mucoadhesive polymers could penetrate CF sputum, and to use these {"}muco-inert particles{"} (MIPs) as non-destructive nanoprobes to characterize the sputum microstructure. Particles as large as 200 nm in diameter that were densely coated with low MW polyethylene glycol (PEG) moved through undiluted CF sputum with average speeds up to 90-fold faster than similarly-sized uncoated particles. On the other hand, the transport of both coated and uncoated 500 nm particles was strongly hindered. The local viscosity of sputum, encountered by the fastest 10{\%} of 200 nm MIPs, was only 5-fold higher than that of water, whereas the bulk viscosity was 10,000-fold higher at low shear rates. Using measured transport rates of various sized MIPs combined with an obstruction-scaling model, we determined that the average 3D mesh spacing of CF sputum is ∼140 ± 50 nm (range: 60-300 nm). Taken together, these results demonstrate that nanoparticles up to 200 nm in diameter that do not adhere to CF sputum can move rapidly through this critical barrier by accessing pores that are filled with a low viscosity fluid. The results also offer hope that desperately needed sputum-penetrating drug- and gene-carrier nanoparticles can be developed for CF.",
keywords = "Lung disease, Mucus, Mucus penetrating particles, Nanoparticle therapeutics, Particle tracking, Rheology",
author = "Suk, {Jung Soo} and Lai, {Samuel K.} and Wang, {Ying Ying} and Laura Ensign-Hodges and Zeitlin, {Pamela L.} and Boyle, {Michael P.} and Hanes, {Justin S}",
year = "2009",
month = "5",
doi = "10.1016/j.biomaterials.2008.12.076",
language = "English (US)",
volume = "30",
pages = "2591--2597",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "13",

}

TY - JOUR

T1 - The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles

AU - Suk, Jung Soo

AU - Lai, Samuel K.

AU - Wang, Ying Ying

AU - Ensign-Hodges, Laura

AU - Zeitlin, Pamela L.

AU - Boyle, Michael P.

AU - Hanes, Justin S

PY - 2009/5

Y1 - 2009/5

N2 - Highly viscoelastic and adhesive sputum has precluded efficient nanoparticle-based drug and gene delivery to the lungs of patients with cystic fibrosis (CF). We sought to determine whether nanoparticles coated with non-mucoadhesive polymers could penetrate CF sputum, and to use these "muco-inert particles" (MIPs) as non-destructive nanoprobes to characterize the sputum microstructure. Particles as large as 200 nm in diameter that were densely coated with low MW polyethylene glycol (PEG) moved through undiluted CF sputum with average speeds up to 90-fold faster than similarly-sized uncoated particles. On the other hand, the transport of both coated and uncoated 500 nm particles was strongly hindered. The local viscosity of sputum, encountered by the fastest 10% of 200 nm MIPs, was only 5-fold higher than that of water, whereas the bulk viscosity was 10,000-fold higher at low shear rates. Using measured transport rates of various sized MIPs combined with an obstruction-scaling model, we determined that the average 3D mesh spacing of CF sputum is ∼140 ± 50 nm (range: 60-300 nm). Taken together, these results demonstrate that nanoparticles up to 200 nm in diameter that do not adhere to CF sputum can move rapidly through this critical barrier by accessing pores that are filled with a low viscosity fluid. The results also offer hope that desperately needed sputum-penetrating drug- and gene-carrier nanoparticles can be developed for CF.

AB - Highly viscoelastic and adhesive sputum has precluded efficient nanoparticle-based drug and gene delivery to the lungs of patients with cystic fibrosis (CF). We sought to determine whether nanoparticles coated with non-mucoadhesive polymers could penetrate CF sputum, and to use these "muco-inert particles" (MIPs) as non-destructive nanoprobes to characterize the sputum microstructure. Particles as large as 200 nm in diameter that were densely coated with low MW polyethylene glycol (PEG) moved through undiluted CF sputum with average speeds up to 90-fold faster than similarly-sized uncoated particles. On the other hand, the transport of both coated and uncoated 500 nm particles was strongly hindered. The local viscosity of sputum, encountered by the fastest 10% of 200 nm MIPs, was only 5-fold higher than that of water, whereas the bulk viscosity was 10,000-fold higher at low shear rates. Using measured transport rates of various sized MIPs combined with an obstruction-scaling model, we determined that the average 3D mesh spacing of CF sputum is ∼140 ± 50 nm (range: 60-300 nm). Taken together, these results demonstrate that nanoparticles up to 200 nm in diameter that do not adhere to CF sputum can move rapidly through this critical barrier by accessing pores that are filled with a low viscosity fluid. The results also offer hope that desperately needed sputum-penetrating drug- and gene-carrier nanoparticles can be developed for CF.

KW - Lung disease

KW - Mucus

KW - Mucus penetrating particles

KW - Nanoparticle therapeutics

KW - Particle tracking

KW - Rheology

UR - http://www.scopus.com/inward/record.url?scp=60149110687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60149110687&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2008.12.076

DO - 10.1016/j.biomaterials.2008.12.076

M3 - Article

VL - 30

SP - 2591

EP - 2597

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 13

ER -